Items where authors include "Ajjan, R.A."

Article

Conning-Rowland, M.S., Giannoudi, M., Drozd, M. et al. (12 more authors) (2024) The diabetic myocardial transcriptome reveals Erbb3 and Hspa2 as a novel biomarkers of incident heart failure. Cardiovascular Research. cvae181. ISSN 0008-6363

Safdar, N.Z. orcid.org/0000-0002-4232-7146, Alobaid, A.M., Hopkins, M. orcid.org/0000-0002-7655-0215 et al. (6 more authors) (2024) Short, frequent, light-intensity walking activity improves postprandial vascular-inflammatory biomarkers in people with type 1 diabetes: The SIT-LESS randomized controlled trial. Diabetes, Obesity and Metabolism. ISSN 1462-8902

Campbell, M.D. orcid.org/0000-0001-5883-5041, Alobaid, A.M., Hopkins, M. orcid.org/0000-0002-7655-0215 et al. (5 more authors) (2023) Interrupting prolonged sitting with frequent short bouts of light-intensity activity in people with type 1 diabetes improves glycaemic control without increasing hypoglycaemia: The SIT-LESS randomised controlled trial. Diabetes, Obesity and Metabolism, 25 (12). pp. 3589-3598. ISSN 1462-8902

Ajjan, R.A. orcid.org/0000-0002-1636-3725, Heller, S.R. orcid.org/0000-0002-2425-9565, Everett, C.C. et al. (11 more authors) (2023) Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial. Diabetes Care, 46 (2). pp. 441-449. ISSN 0149-5992

Ajjan, R.A. orcid.org/0000-0002-1636-3725, Heller, S.R. orcid.org/0000-0002-2425-9565, Everett, C.C. et al. (11 more authors) (2023) Multicenter randomized trial of intermittently scanned continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes and recent-onset acute myocardial infarction: results of the LIBERATES trial. Diabetes Care, 46 (2). dc221219. ISSN 0149-5992

Parker, W.A.E. orcid.org/0000-0002-7822-8852, Sagar, R., Kurdee, Z. et al. (5 more authors) (2021) A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes : role of dosing and glycaemic control. Cardiovascular Diabetology, 20 (1). 238.

Pechlivani, N. orcid.org/0000-0001-5041-5763, Kearney, K.J. orcid.org/0000-0002-0387-6812 and Ajjan, R.A. orcid.org/0000-0002-1636-3725 (2021) Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics. International Journal of Molecular Sciences, 22 (22). 12537. ISSN 1661-6596

McPherson, H.R., Duval, C., Baker, S.R. et al. (10 more authors) (2021) Fibrinogen αC-subregions critically contribute blood clot fibre growth, mechanical stability, and resistance to fibrinolysis. eLife, 10. e68761. ISSN 2050-084X

Duval, C., Baranauskas, A., Feller, T. et al. (14 more authors) (2021) Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi. Proceedings of the National Academy of Sciences, 118 (27). e2103226118. ISSN 0027-8424

Ajjan, R.A., Kietsiriroje, N., Badimon, L. et al. (6 more authors) (2021) Antithrombotic therapy in diabetes: which, when, and for how long? European Heart Journal, 42 (23). pp. 2235-2259. ISSN 0195-668X

Ajjan, R.A. orcid.org/0000-0002-1636-3725, Kietsiriroje, N. orcid.org/0000-0002-5076-4450, Badimon, L. et al. (6 more authors) (2021) Antithrombotic therapy in diabetes: which, when, and for how long? European Heart Journal, 42 (23). pp. 2235-2259. ISSN 0195-668X

Altalhi, R., Pechlivani, N. orcid.org/0000-0001-5041-5763 and Ajjan, R.A. orcid.org/0000-0002-1636-3725 (2021) PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target. International Journal of Molecular Sciences, 22 (6). 3170. ISSN 1661-6596

Parker, W.A.E. orcid.org/0000-0002-7822-8852, Schulte, C., Barwari, T. et al. (6 more authors) (2020) Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus : a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels. Cardiovascular Diabetology, 19 (1). 3.

Everett, C.C., Reynolds, C., Fernandez, C. et al. (6 more authors) (2020) Rationale and design of the LIBERATES trial : protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarction. Diabetes and Vascular Disease Research, 17 (5). ISSN 1479-1641

Braza-Boïls, A., Barwari, T., Gutmann, C. et al. (9 more authors) (2020) Circulating microRNA levels indicate platelet and leukocyte Aativation in endotoxemia despite platelet P2Y12 inhibition. International Journal of Molecular Sciences, 21 (8). 2897. ISSN 1661-6596

Sumaya, W., Wallentin, L., James, S.K. et al. (5 more authors) (2020) Impaired fibrinolysis predicts adverse outcome in acute coronary syndrome patients with diabetes: A PLATO sub-study. Thrombosis and Haemostasis, 120 (03). pp. 412-422. ISSN 0340-6245

Parker, W.A.E. orcid.org/0000-0002-7822-8852, Orme, R.C., Hanson, J. et al. (11 more authors) (2019) Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. Platelets, 30 (2). pp. 148-157. ISSN 0953-7104

Sumaya, W., Parker, W.A.E. orcid.org/0000-0002-7822-8852, Fretwell, R. et al. (12 more authors) (2018) Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study). Thrombosis and Haemostasis , 118 (7). pp. 1250-1256. ISSN 0340-6245

Sumaya, W., Wallentin, L., James, S.K. et al. (6 more authors) (2018) Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy. European Heart Journal. ehy013. ISSN 0195-668X

Thomas, M.R., Outteridge, S.N., Ajjan, R.A. et al. (10 more authors) (2015) Platelet P2Y(12) Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model. Arteriosclerosis, Thrombosis, and Vascular Biology, 35 (12). pp. 2562-2570. ISSN 1079-5642

Kemp, E.H., Ajjan, R.A., Metcalfe, R.A. et al. (2 more authors) (2015) IL-14 and IL-16 are expressed in the thyroid of patients with either Graves' disease or Hashimoto's thyroiditis. Clinical Endocrinology, 83 (5). pp. 726-732. ISSN 0300-0664

Elwen, F.R., Huskinson, A., Clapham, L. et al. (6 more authors) (2015) An observational study of patient characteristics and mortality following hypoglycemia in the community. BMJ Open Diabetes Research and Care, 3 (1). e000094. ISSN 2052-4897

Ajjan, R.A. and Weetman, A.P. (2015) The Pathogenesis of Hashimoto's Thyroiditis: Further Developments in our Understanding. Hormone and Metabolic Research, 47 (10). 702 -710. ISSN 0018-5043

Preprint

McPherson, H.R., Duval, C. orcid.org/0000-0002-4870-6542, Baker, S.R. et al. (10 more authors) (2021) Fibrinogen αC-subregions critically contribute blood clot fibre growth, mechanical stability and resistance to fibrinolysis. [Preprint]